Pharm Exec’s annual listing of the top biopharma players shows that most are holding their ground as they weigh a more challenging business climate with new opportunities for growth in a potentially resurgent marketplace
martes, 11 de septiembre de 2018
Pharm Exec's Top 50 Companies 2018 (I)
Pharm Exec’s annual listing of the top biopharma players shows that most are holding their ground as they weigh a more challenging business climate with new opportunities for growth in a potentially resurgent marketplace
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario